×
Please click
here
if you are not redirected within a few seconds.
All
News
Maps
Images
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Monopar Announces CFO Succession
GlobeNewswire
WILMETTE, Ill., May 24, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage radiopharmaceutical company...
2 days ago
Monopar Therapeutics (MNPR) Catches Eye: Stock Jumps 11.2%
Yahoo Movies Canada
Monopar Therapeutics Inc. MNPR was a big mover last session, as the company saw its shares rise more than 11% on the day.
4 days ago
Monopar Therapeutics appoints new CFO as Tsuchimoto retires By Investing.com
Investing.com
WILMETTE, Ill. - Monopar Therapeutics Inc . (NASDAQ: NASDAQ:MNPR), a clinical-stage company specializing in radiopharmaceutical cancer...
2 days ago
HC Wainwright & Co. Reiterates Monopar Therapeutics (MNPR) Buy Recommendation
MSN
Fintel reports that on June 1, 2023, HC Wainwright & Co. reiterated coverage of Monopar Therapeutics (NASDAQ:MNPR) with a Buy recommendation.
5 days ago
Bears are Losing Control Over Monopar Therapeutics (MNPR), Here's Why It's a 'Buy' Now
Zacks Investment Research
Shares of Monopar Therapeutics Inc. ( MNPR Quick Quote MNPR - Free Report) have been struggling lately and have lost 13.2% over the past...
1 week ago
MNPR Stock Quote Price and Forecast
CNN
Monopar Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing proprietary therapeutics for cancer patients.
2 months ago
Monopar Therapeutics Begins Phase 1 Cancer Imaging Trial - TipRanks.com
Tipranks
Monopar Therapeutics Inc (MNPR) has provided an update. Monopar Therapeutics Inc. has announced the commencement of its Phase 1 dosimetry clinical trial for...
1 month ago
Monopar Therapeutics Inc Reports Q3 2023 Financial Results and Progress in Clinical Programs
Yahoo Finance
Monopar Therapeutics Inc Reports Q3 2023 Financial Results and Progress in Clinical Programs · Monopar Therapeutics Inc (NASDAQ:MNPR) announces...
6 months ago
Monopar Therapeutics Reports First Quarter 2024 Financial Results and Strategic Focus on its Radiopharma Pipeline
GlobeNewswire
Initiated MNPR-101-Zr First-in-Human Phase 1 Radiopharma Clinical Trial MNPR-101-RIT Phase 1 Clinical Trial Targeted for Launch as Early as...
2 weeks ago
Monopar Receives Clearance to Proceed with First-in-Human Phase 1 Trial of Novel Radiopharmaceutical MNPR-101 ...
Yahoo Finance
WILMETTE, Ill., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company...
3 months ago